J. Margery

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Gérard Zalcman, Julien Mazières, J. Margery et al. · The Lancet · 2015 · 972 citations

Medicine, Oncology, Pharmacology +10

Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002

S. Couraud, Felipe Vaca‐Paniagua, Stéphanie Villar et al. · Clinical Cancer Research · 2014 · 211 citations

Medicine, Molecular Genetics, Oncology +17

Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort

Solenn Brosseau, Claire Danel, Arnaud Scherpereel et al. · Clinical Lung Cancer · 2019 · 63 citations · Full text

Medicine, Oncology, Pathology +17

Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?

J. Damiano, L. Bordier, JP Le Berre et al. · Diabetes & Metabolism · 2004 · 60 citations

Medicine, Internal Medicine, Radiology +12

Phase II Study of Vinflunine in Malignant Pleural Mesothelioma

Denis Talbot, J. Margery, G Dabouis et al. · Journal of Clinical Oncology · 2007 · 43 citations · Full text

Medicine, Oncology, Pharmacology +16